Monsanto Company (MON) : Analyst Rating Update

Monsanto Company (MON) : The consensus on Monsanto Company (MON) based on 13 analyst recommendation on the company stock is 1.92, which is interpreted as a Buy recommendation. Zacks Investment Research has issued a rank of 4 which endorses a Sell on the stock. However, 7 brokers have a differing view as they consider the stock to be a Strong Buy at current levels. 6 experts consider that the stocks earnings and the quoted price is in harmony, hence, they give it a Hold rating.

Monsanto Company (MON) : The consensus price target for Monsanto Company (MON) is $107.2 for the short term with a standard deviation of $15.57. The most optimist securities analyst among the 10 who monitor the stock believes that the stock can reach $132, however, the pessimist price target for the company is $88.

Monsanto Company (NYSE:MON): The stock opened at $99.84 on Wednesday but the bulls could not build on the opening and the stock topped out at $101.26 for the day. The stock traded down to $99.39 during the day, due to lack of any buying support eventually closed down at $99.40 with a loss of -0.31% for the day. The stock had closed at $99.71 on the previous day. The total traded volume was 3,463,924 shares.

Also, Brokerage firm Citigroup maintains its rating on Monsanto Company (NYSE:MON). As per the latest information, the brokerage house raises the price target to $112 per share from a prior target of $94. The shares have been rated Neutral. The rating by the firm was issued on July 1, 2016. The company shares have dropped -5.41% from its 1 Year high price. On Jun 10, 2016, the shares registered one year high at $114.26 and the one year low was seen on Sep 24, 2015. The 50-Day Moving Average price is $106.40 and the 200 Day Moving Average price is recorded at $95.07.

Monsanto Company (Monsanto) is a provider of agricultural products for farmers. The Companys seeds, biotechnology trait products, and herbicides provide farmers with solutions that improve productivity, reduce the costs of farming, and produce better foods for consumers and better feed for animals. It manages business in two segments: Seeds and Genomics, and Agricultural Productivity. Through its Seeds and Genomics segment, it produces seed brands, including DEKALB, Asgrow, Deltapine, Seminis and De Ruiter, and it develops biotechnology traits that assist farmers in controlling insects and weeds. Through its Agricultural Productivity segment, it manufactures Roundup brand herbicides and other herbicides and provides lawn-and-garden herbicide products for the residential market.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.